1. van Schalkwyk DA History of antimalarial agents. In: eLS. John Wiley & Sons, Ltd: Chichester; 2015. p. 1–5. https://onlinelibrary.wiley.com/doi/10.1002/9780470015902.a0003624.pub3
2. Uzor PF. Alkaloids from plants with antimalarial activity: A review of recent studies. Evid-Based Complement Alter Med 2020;2020:1–17. https://www.hindawi.com/journals/ecam/2020/8749083/
3. Porta EOJ, Bofill Verdaguer I, Perez C, Banchio C, Ferreira de Azevedo M, Katzin AM, et al. Repositioning salirasib as a new antimalarial agent. Medchemcomm 2019;10:1599–605. http://xlink.rsc.org/?DOI=C9MD00298G
4. Guerin PJ, Olliaro P, Nosten F, Druilhe P, Laxminarayan R, Binka F, et al. Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis. 2002;2:564–73. https://linkinghub.elsevier.com/retrieve/pii/S1473309902003729
5. Muregi FW, Ishih A. Next-generation antimalarial drugs: hybrid molecules as a new strategy in drug design. Drug Dev Res. 2009;71:20–32. https://onlinelibrary.wiley.com/doi/10.1002/ddr.20345